Matches in Wikidata for { <http://www.wikidata.org/entity/Q92742057> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q92742057 description "article scientifique publié en 2019" @default.
- Q92742057 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92742057 description "scientific article published on 27 August 2019" @default.
- Q92742057 description "wetenschappelijk artikel" @default.
- Q92742057 description "наукова стаття, опублікована 27 серпня 2019" @default.
- Q92742057 name "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 name "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 type Item @default.
- Q92742057 label "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 label "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 prefLabel "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 prefLabel "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 P1433 Q92742057-C9EE9F89-BB8D-4670-877C-C5E575A76335 @default.
- Q92742057 P1476 Q92742057-9A6550F7-DFEE-4782-A4AD-34B0F8487F0B @default.
- Q92742057 P2093 Q92742057-0F801DBE-15BD-4833-A8FC-328CFA0A7C16 @default.
- Q92742057 P2093 Q92742057-1F8F44B6-C7B3-45A9-903F-82D819F66078 @default.
- Q92742057 P2093 Q92742057-4B006F2A-0D92-4582-986F-83F6BD35CAE0 @default.
- Q92742057 P2093 Q92742057-4F13D75B-CA65-4828-8182-118AD6095242 @default.
- Q92742057 P2093 Q92742057-8E79FBCC-5682-4311-BC85-B085799CCFC2 @default.
- Q92742057 P2093 Q92742057-94300F91-8ABA-4EFE-B2E2-E6F271FFF768 @default.
- Q92742057 P2093 Q92742057-FA5A153B-6CA6-472D-9F99-C1090FDFF100 @default.
- Q92742057 P275 Q92742057-5DFA4073-1C90-4D74-918F-9F09457586AF @default.
- Q92742057 P304 Q92742057-F698D084-E353-48CD-BC59-168259F1D920 @default.
- Q92742057 P31 Q92742057-7E72D94A-97C4-48A6-A5D1-8980E6CA6323 @default.
- Q92742057 P356 Q92742057-85A17FAF-A5CB-4DCA-8E3F-8C3C78DB8897 @default.
- Q92742057 P433 Q92742057-39ABA256-0409-428C-8477-1929BA8C71EC @default.
- Q92742057 P478 Q92742057-DED6AE68-AE1B-4173-9B6D-DE5570018475 @default.
- Q92742057 P577 Q92742057-51776E7A-4592-4154-9686-0BC77496B3DD @default.
- Q92742057 P6216 Q92742057-B446C93A-CC5C-4B45-B205-16D81FC4C0C5 @default.
- Q92742057 P698 Q92742057-08232079-C92F-4830-A046-D760AF4F8D2D @default.
- Q92742057 P356 00498254.2019.1654634 @default.
- Q92742057 P698 31432741 @default.
- Q92742057 P1433 Q1360678 @default.
- Q92742057 P1476 "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans" @default.
- Q92742057 P2093 "Ajith Welihinda" @default.
- Q92742057 P2093 "Geoff E Stilwell" @default.
- Q92742057 P2093 "Haifeng Ding" @default.
- Q92742057 P2093 "Wenbin Zhang" @default.
- Q92742057 P2093 "Xiaoyan Li" @default.
- Q92742057 P2093 "Yuan Lu" @default.
- Q92742057 P2093 "Yuan-Di Halvorsen" @default.
- Q92742057 P275 Q24082749 @default.
- Q92742057 P304 "559-569" @default.
- Q92742057 P31 Q13442814 @default.
- Q92742057 P356 "10.1080/00498254.2019.1654634" @default.
- Q92742057 P433 "5" @default.
- Q92742057 P478 "50" @default.
- Q92742057 P577 "2019-08-27T00:00:00Z" @default.
- Q92742057 P6216 Q50423863 @default.
- Q92742057 P698 "31432741" @default.